SCHEMBL23439713

SCHEMBL23439713

O=C(NCc1ccco1)c1ccccc1NSc1ccc(Br)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 10/20 0.60
▸ POLB P06746 4/20 0.60
▸ HTT P42858 3/20 0.60
▸ MAPT P10636 4/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ ALDH1A1 P00352 6/20 0.53
▸ MEN1 O00255 4/20 0.53
▸ KMT2A Q03164 4/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ KDM4E B2RXH2 4/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.52
▸ USP2 O75604 2/20 0.52
▸ RAB9A P51151 1/20 0.50
▸ CASP3 P42574 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49
▸ SENP6 Q9GZR1 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ TSHR P16473 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23440431 0.91 NPSR1 (0.60) HPGDPOLBHTTMAPTSMN1; SMN2
SCHEMBL23440341 0.89 SMN1; SMN2 (0.61) HPGDPOLBHTTMAPTSMN1; SMN2
SCHEMBL23440433 0.89 TDP1 (0.58) HPGDPOLBHTTMAPTSMN1; SMN2
SCHEMBL23440348 0.85 HPGD (0.60) HPGDPOLBHTTMAPTSMN1; SMN2
SCHEMBL23440346 0.84 HPGD (0.56) HPGDPOLBHTTMAPTSMN1; SMN2
SCHEMBL23440117 0.81 HPGD (0.51) HPGDPOLBHTTMAPTSMN1; SMN2
SCHEMBL23439800 0.81 HPGD (0.51) HPGDPOLBHTTMAPTSMN1; SMN2
SCHEMBL23412537 0.79 HPGD (0.71) HPGDPOLBHTTMAPTSMN1; SMN2
SCHEMBL16676602 0.76 HPGD (0.66) HPGDPOLBHTTMAPTSMN1; SMN2
SCHEMBL31092083 0.76 HPGD (1.00) HPGDPOLBHTTMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021105906-A1 ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE GAIN THERAPEUTICS SA (CH) 2021-06-03 — — WO disclosed
Send feedback